From the category archives:

Press Releases

Nick Jonas, one third of the Grammy-nominated, multi-platinum group the Jonas Brothers, was announced today as  the National Chair of JDRF’s Walk to Cure Diabetes.

Nick Jonas, 17, was diagnosed with type 1 diabetes when he was 13 years old.  He becomes the key figure for the largest fundraising program for the Juvenile Diabetes Research Foundation. In this role, Nick will help JDRF increase participation and fundraising in its annual Walks, held in more than 200 locations worldwide.  Nearly 500,000 people took part in JDRF Walks last year, raising some $75 million.  As the National Chair, Nick will attend events to support fundraising efforts as well as take part in promotional videos and television public service announcements for JDRF.

Watch the NEW Walk to Cure Diabetes Video

To register for a Walk near you, visit Walk.JDRF.org

“As a person living day to day with diabetes and recognizing the tremendous contribution the Juvenile Diabetes Research Foundation has done for our community, I couldn’t be more honored to serve as the National Chair for the Walk to Cure Diabetes,” says Nick Jonas.

“Having Nick Jonas as National Chair will go far towards raising awareness of type 1 diabetes, and what needs to be done to find a cure. Nick has been a wonderful role model for kids and adults with diabetes, and has been invaluable in bringing visibility to efforts to cure this disease,” said Leo Mullin, Chairman of Board of Directors for JDRF.  “We have seen the impact he has firsthand, when he demonstrated his commitment to support diabetes research through the Jonas Brothers’ Change for the Children Foundation, and when he testified in Congress for JDRF on the need for continued federal funding for research.”

In addition, Nick has helped raise diabetes awareness through his partnership with Bayer Diabetes Care.  Last month, Bayer and Nick Jonas announced a new contest called “Give Back. Simply Win.” that encourages people with diabetes to share their stories about giving back, and rewards them for their charitable efforts.  For more information on this contest, please visit www.nickssimplewins.com.

Nick succeeds actor and celebrity advocate Kevin Kline, who was National Chair of JDRF’s Walk to Cure Diabetes for the past four years.

{ 0 comments }

JDRF Names Jeffrey Brewer as President & Chief Executive Officer

by Greg Martin06.17.2010

ShareJDRF Volunteer, Philanthropist, Former Internet Executive to Lead Top Funder of Cures and Treatments for People with Type 1 Diabetes and Its Complications
The Juvenile Diabetes Research Foundation, the leader in type 1 diabetes research worldwide, announced today that Jeffrey Brewer has been named President and Chief Executive Officer.
Mr. Brewer, an entrepreneur and philanthropist, has been [...]

Read the full article →

Alan Lewis Resigns as President & CEO of JDRF

by Patrick McKowen05.14.2010

ShareContact:
William J. Ahearn: (212) 479-7531 wahearn@jdrf.org
Joana Casas: (212) 479-7560 mcasas@jdrf.org
New York, May 13, 2010 : The Juvenile Diabetes Research Foundation International, the world’s largest charitable funder of research leading to a cure for type 1 diabetes and its complications, said on Thursday, May 13, 2010, that President and Chief Executive Officer Alan J. Lewis, PhD, is resigning. [...]

Read the full article →

Nick Jonas’ Contest For People With Type 1 Diabetes

by Greg Martin05.11.2010

ShareSimple Wins, according to Bayer, are small, everyday victories one  achieves in life with diabetes that add up to big wins over time. One of Nick Jonas’ Simple Wins is being able to give back to the community and inspire others to do the same. That’s why Bayer Diabetes Care (a.k.a. Bayer Health Care LLC) [...]

Read the full article →

JDRF Names Frank Ingrassia Chairman of the International Board of Directors

by Greg Martin04.27.2010

ShareThe Juvenile Diabetes Research Foundation International is pleased to announce that Frank Ingrassia has been named Chairman of the Board. Mr. Ingrassia is President and Chief Executive Officer of Clever Devices, Ltd.; he is the former Chairman of the Public Finance Group at Goldman Sachs & Co.
Mr. Ingrassia has been involved with JDRF for [...]

Read the full article →

Novel Artificial Pancreas System Using Two Hormones Successfully Controls Blood Sugar Levels In Type 1 Diabetes Patients

by Patrick McKowen04.16.2010

ShareMedia Contact: Joana Casas, (212) 479-7560, mcasas@jdrf.org
NEW YORK, April 14, 2010 —   In a clinical trial that studied the benefits of a unique artificial pancreas system utilizing two hormones to control blood sugar, patients were able to achieve near-normal sugar levels for more than 24 hours without hypoglycemia, or low blood sugar.  The results [...]

Read the full article →

Qualitest Pharmaceuticals Issues a Voluntary Nationwide Recall of All Accusure® Insulin Syringes

by Greg Martin10.30.2009

Share

This press release was released by the company three days ago.  We hope you received the news faster than we received it here.
FOR IMMEDIATE RELEASE – October 27, 2009 – Huntsville AL-Qualitest Pharmaceuticals today issued a voluntary nationwide recall of all Accusure® Insulin Syringes. The distributed syringes are of the following descriptions and NDC [...]

Read the full article →

FDA Alert

by Greg Martin08.14.2009

ShareAugust 14, 2009
The FDA has issued an alert about the possibility that people with type 1 diabetes who take certain medicines that contain non-glucose sugars might get falsely elevated readings from home blood sugar monitors if they use a specific kind of test strip.  These false high readings could be dangerous, because they might mask [...]

Read the full article →